Navigation Links
InVitria to Present at BIO 2009 International Convention in Atlanta
Date:5/19/2009

InVitria to profile "New Strategies for Optimizing CHO Performance" inside the BIO Process Product Zone on May 20, 2009 in Atlanta, GA.

Fort Collins, CO (PRWEB) May 19, 2009 -- Amidst the sea of people, products and presentations at the BIO 2009 International Convention will be InVitria, a cell culture media supplement company that provides performance enhancing components for CHO and hybridoma cell culture media. InVitria's cell culture media supplement products will be part of the BIO Process Product Zone exhibition in Booth #5120 within the Georgia World Congress Center from May 18-21.

InVitria's products will also be showcased in the BioProcess Theater, a site located on the exhibition floor and sponsored by BioProcess International to facilitate the sharing of advances and discoveries in the biopharmaceutical sector. InVitria's Director of Cell Culture, Dr. Steve Pettit, will present the performance enhancing features of ZAP-CHO, a new media component for Chinese hamster ovary (CHO) cell culture. Dr. Pettit will present the advantages of this new cell culture supplement at 3:30 pm on Wednesday, May 20 inside the BioProcess Theater.

ZAP-CHO, a new product from InVitria, enhances performance of mammalian cell culture including improved cell growth and antibody production. It achieves these performance advantages in chemically defined media that are completely free of animal components. Previously, the performance seen with ZAP-CHO was only possible by utilizing animal components such as FBS (fetal bovine serum), BSA (bovine serum albumin) or plasma-derived HSA (human serum albumin) in cell culture media.

"Our team of scientists has developed supplements that not only meet the regulatory requirements of researchers using hybridoma and CHO cell culture, but it exceeds their performance expectations as well," said Dr. Pettit. "InVitria products have
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. InVitria Reveals Technology to Optimize Hybridoma Production Performance
2. InVitria Headlines Sponsorship of WilBio's Waterside Conference
3. InVitria Announces Launch of Recombinant Albumin for Diagnostics
4. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
5. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
6. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
7. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
8. InVitria to Present at WilBio's International Cell Engineering Meeting
9. Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting
10. Olanzapine Long-Acting Injection (LAI) Efficacy and Safety Data Presented at American Psychiatric Association Annual Meeting
11. Covance to Present at the Deutsche Bank 34th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... This Fall, as Ovarian ... Bright Pink, a national non-profit focused on the prevention and early detection of ... campaign to educate women to be breast and ovarian self-aware and celebrate positive, ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... Traveling to ... a wide array of magnificent flora and fauna. , Lifestyle Holidays Vacation ... well-preserved history. To help make travelers experience that much better, Lifestyle Holidays Vacation Club ...
(Date:9/1/2015)... Hills, CA (PRWEB) , ... September 01, 2015 ... ... International Business Times discusses the hundreds of thousands of plastic surgeries conducted each ... media and reality TV for the growing numbers. Beverly Hills-based plastic surgeon Payam ...
(Date:9/1/2015)... ... , ... September is National Prostate Cancer Awareness Month and Florida Hospital Zephyrhills ... year in the United States. , Prostate cancer is to men what breast cancer ... in 7 men. One new case occurs every 2.3 minutes and a man dies ...
(Date:9/1/2015)... ... September 01, 2015 , ... The Capillus82™ has ... of androgenic alopecia in adults, announces Miami-based medical device manufacturer, Capillus, LLC. FDA ... demonstrating its safety when used at home to combat hair loss. , ...
Breaking Medicine News(10 mins):Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2
... staff members working in a hospital,s fast-paced emergency department ... involved in medication errors that harm patients, new Johns ... serious issues related to temporary nursing staff in particular ... of the health care workforce owing to the national ...
... SUNY Downstate Medical Center have received a $50,000 grant ... develop a diagnostic test for the folate receptor autoantibody. ... cerebral folate deficiency in infants and autism spectrum disorders. ... United States, neural tube defects result in the brain ...
... to make people "tear up," but a new study led by ... nasal spray containing an ingredient derived from hot chili peppers ( ... sinus inflammation. The study, which appears in the August ... compares the use of the Capsicum annum nasal spray ...
... (HealthDay News) -- Interbreeding between modern humans, Neanderthals and ... boost peoples, immune systems today, researchers report. Modern ... share a common African ancestor, the team of scientists ... Science . However, the groups diverged into separate, distinct ...
... hormone receptor guanylyl cyclase C (GCC) has been established ... evidence from Thomas Jefferson University suggests it ... pandemics: obesity. Reporting in the August 25 ... Scott Waldman, M.D., Ph.D., chairman of the ...
... , THURSDAY, Aug. 25 (HealthDay News) -- For kids, the end ... sleeping until noon: It also signals the beginning of brand new ... your child is a preschooler or a teen, some anxiety about ... is to know how to ease your children,s stress and manage ...
Cached Medicine News:Health News:Temporary ER staff poses increased safety risk to patients 2Health News:Temporary ER staff poses increased safety risk to patients 3Health News:Researchers developing new test to measure risk for birth defects and neuro-developmental disorders 2Health News:Thank Neanderthals for That Healthy Immune System, Scientists Say 2Health News:Could a tumor suppressor also fight obesity? 2Health News:Parents Can Ease Back-to-School Stress 2Health News:Parents Can Ease Back-to-School Stress 3
(Date:9/1/2015)... BEDFORD, Mass. , Sept. 1, 2015 ... investigating whether certain officers and directors of ... Act of 1934.  ConforMIS is a medical technology company ... manufacture, and sell joint replacement implants that are individually ... View this press release on the law ...
(Date:9/1/2015)... Va. , Sept. 1, 2015  AccuTec Blades, ... Company,s (EPC) Industrial Blades division.  EPC announced in May ... in Verona, Virginia and ... completion of the sale process. ... Officer of AccuTec Blades said, "Our new name, AccuTec ...
(Date:9/1/2015)... BRUSSELS , Sept. 1, 2015 /PRNewswire/ ... Brussels: UCB) today announced top-line results from the ... with Teriparatide in postmenopaUsal women with osteoporosis at ... therapy). The study (NCT01796301) met the primary endpoint, ... romosozumab in the percent change of total hip ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of ConforMIS, Inc. (CFMS) on Behalf of Shareholders 2AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9
... Adding MabThera to first line chemotherapy significantly,increases ... May, 2007) _ In a study published,yesterday ... (rituximab),plus chemotherapy (MCP*) was shown to significantly ... compared to,chemotherapy alone.1 Follicular lymphoma is the ...
... of 10 non-diabetic patients treated with,Exforge achieved recommended blood ... mmHg in,systolic blood pressure observed in patients taking Exforge ... of those with high blood pressure not,at treatment target ... goal[2] , , , BASEL, ...
Cached Medicine Technology:Innovative Cancer Drug MabThera Again Shown To Improve Survival,Rates In Patients With Lymphoma 2Innovative Cancer Drug MabThera Again Shown To Improve Survival,Rates In Patients With Lymphoma 3Innovative Cancer Drug MabThera Again Shown To Improve Survival,Rates In Patients With Lymphoma 4Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 2Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 3Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 4Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 5Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 6Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 7Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 8
... VerdaSee Mobile Location-ID™ offers a for asset ... are attached to all the assets that will ... device, is equipped with a reader, antenna, and ... be as small as 10 inches x 6 ...
... provides hospitals with a suite ... all their supplies, drugs, assets, ... remove all manual compliance from ... accurately. iRIS, or Intelligent Radio-Frequency ...
Agility can provide tracking and management of surgical instruments, instrument trays and case carts to significantly enhance the current central sterile department flow by improving efficiency....
The WatchMate MR model displays multiple alarms locally without individual identification, but ID numbers and names can be displayed at a central station. Alarms may be cleared locally under password...
Medicine Products: